cliffwatch

Applicant, as named in the Orange Book

Boehringer Ingelheim

Next listed expiry: Striverdi Respimat on 19 Jan 2027. 16 products with live protection, 6 without.

Products with listed protection

DrugEarliest generic entry
Striverdi Respimat
olodaterol hydrochloride
19 Jan 2027
Stiolto Respimat
olodaterol hydrochloride; tiotropium bromide
13 Sep 2028
Ofev · 2 strengths
nintedanib esylate
7 Dec 2029
Gilotrif · 3 strengths
afatinib dimaleate
5 Jan 2031
Spiriva Respimat · 2 strengths
tiotropium bromide
16 Apr 2031
Pradaxa · 3 strengths
dabigatran etexilate mesylate
20 Jul 2031
Synjardy · 4 strengths
empagliflozin; metformin hydrochloride
17 Nov 2034
Jardiance · 2 strengths
empagliflozin
11 Dec 2034
Synjardy Xr · 4 strengths
empagliflozin; metformin hydrochloride
11 Dec 2034
Glyxambi · 2 strengths
empagliflozin; linagliptin
8 Dec 2037
Jentadueto · 3 strengths
linagliptin; metformin hydrochloride
8 Dec 2037
Jentadueto Xr · 2 strengths
linagliptin; metformin hydrochloride
8 Dec 2037
Tradjenta
linagliptin
8 Dec 2037
Trijardy Xr · 4 strengths
empagliflozin; linagliptin; metformin hydrochloride
8 Dec 2037
Jascayd · 2 strengths
nerandomilast
22 Oct 2038
Hernexeos
zongertinib
21 Jul 2041

Recent events

  • 25 Oct 2026Ofev · Generic tentatively approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Jardiance · Generic tentatively approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Mexitil · Generic approved
  • 25 Oct 2026Jardiance · Generic approved
  • 25 Oct 2026Atrovent Hfa · First generic approved
  • 25 Oct 2026Atrovent Hfa · Generic approved
  • 25 Oct 2026Mexitil · Generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Ofev · First generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Ofev · First generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Trijardy Xr · Generic tentatively approved
  • 25 Oct 2026Jentadueto · Generic approved
  • 25 Oct 2026Tradjenta · Generic approved
  • 25 Oct 2026Ofev · First generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Ofev · First generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Tradjenta · Generic approved
  • 25 Oct 2026Tradjenta · Generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Tradjenta · Generic approved
  • 25 Oct 2026Jentadueto · Generic approved
  • 25 Oct 2026Tradjenta · Generic approved
  • 25 Oct 2026Gilotrif · Generic tentatively approved
  • 25 Oct 2026Ofev · First generic approved
  • 25 Oct 2026Ofev · Generic approved
  • 25 Oct 2026Gilotrif · First generic approved
  • 25 Oct 2026Gilotrif · Generic approved
  • 25 Oct 2026Gilotrif · First generic approved
  • 25 Oct 2026Gilotrif · Generic approved
  • 24 Oct 2026Tradjenta · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jentadueto · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jentadueto · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jentadueto · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jardiance · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jardiance · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy Xr · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy Xr · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy Xr · Exclusivity expires within 90 days PED
  • 24 Oct 2026Synjardy Xr · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jentadueto Xr · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jentadueto Xr · Exclusivity expires within 90 days PED
Products without listed protection (6)
DrugEarliest generic entry
Aptivus
tipranavir
open now
Atrovent Hfa
ipratropium bromide
open now
Combivent Respimat
albuterol sulfate; ipratropium bromide
open now
Micardis Hct · 3 strengths
hydrochlorothiazide; telmisartan
open now
Pradaxa · 6 strengths
dabigatran etexilate mesylate
open now
Spiriva
tiotropium bromide
open now